Browse

Establishment and characterization of EBV positive B-lymphoblastoid cell lines derived from cancers
암환자로부터 유래된 EBV 양성 B 림프구 세포주의 수립과 특성분석 연구

Cited 0 time in Web of Science Cited 0 time in Scopus
Authors
장희재
Advisor
구자록
Major
의과대학 협동과정 종양생물학전공
Issue Date
2017-08
Publisher
서울대학교 대학원
Keywords
Epstein-Barr virusB-lymphoblastoid cell linelatent geneco-cultureapoptosis
Description
학위논문 (석사)-- 서울대학교 대학원 의과대학 협동과정 종양생물학전공, 2017. 8. 구자록.
Abstract
The international agency for research on cancer estimates that one in five cancer cases worldwide are caused by infection, with most caused by viruses. Viruses have been central to modern cancer research and provide profound insights into both infectious and non-infectious cancer causes. Many studies have been conducted on this, and the link between virus infection and cancer development is increasing (1, 2).
Epstein-Barr virus (EBV), one of the typical virus that causes cancer, is a γ-herpes viruses. EBV infection of resting B lymphocytes in vitro give rise to spontaneous outgrowth of EBV-transformed cell lines, referred to as lymphoblastoid cell lines (LCLs) in previous studies (2, 3). But, in this study, the cell lines established by the proliferation of EBV-infected lymphocytes in tissue during cell culture for establishment of tumor cell lines are referred LCLs.
These LCLs are easy to handle and to maintain so that they are suitable material for biological research (4). Although there are many studies relating LCLs with cancer therapy (5, 6, 7), there has not yet been a study to confirm the presence of anticancer
effect in the same patient by using LCLs itself.
Therefore, we performed type analysis and characterization of LCLs which were established by in vitro proliferation of EBV-infected lymphocytes in tissues during cell culture for establishment of tumor cell lines and we tried to show anticancer effect by approach of new immunotherapy for cancer by these LCLs having EBV specificity.
All LCLs were found to have different origins, EBV was predominantly infected with lymphocytes, and EBNA 1, EBNA 3A, EBNA 3C, BARF 1 and LMP 1 genes were expressed by EBV infection. Using a specific cell surface marker, we could prove that most of the LCLs correspond to B cells. The proliferation assay of LCL having the characteristics of EBV showed that it was sensitive to ganciclovir, and in order to confirm whether it had an anticancer effect in fact, co-culture with cancer cell was performed in vitro and identified that cancer growth tended to be suppressed.
In this study revealed that characterization of EBV positive B-lymphoblastoid cell lines naturally derived from cancer patients by wright staining, PCR, RT-PCR, western blot, Flow cytometry and cell proliferation assays, and identified that LCLs induce apoptosis of cancer cell line. I think that this steady study of LCLs could act as a biomaterial that can be used to treat cancer and disease related to EBV in the future.
Language
English
URI
https://hdl.handle.net/10371/138006
Files in This Item:
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Program in Cancer Biology (협동과정-종양생물학전공)Theses (Master's Degree_협동과정-종양생물학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse